Hjem › Krampeanfald › New Jersey
Krampeanfald kliniske forsøg i New Jersey
8 studier for Krampeanfald søger deltagere på steder i New Jersey.
Byer i New Jersey
Officiel studietekst (engelsk)
An Efficacy and Safety Study of Clemizole HCl in Patients With Lennox-Gastaut Syndrome
- Tekton Research, Marlboro
RekruttererFase 3
Alder 2 til 55 · Alle køn · Opdateret 2. okt. 2026 · NCT05066217A Study to Evaluate the Efficacy and Safety of Cannabidiol Oral Solution (CBD-OS [GWP42003-P, JZP926]) for the Treatment of Focal-Onset Seizures
- Hackensack Meridian Neuroscience Institute at JFK University Medical Center, Edison
- Saint Peter's University Hospital, New Brunswick
RekruttererFase 1
Alder 12 til 75 · Alle køn · Opdateret 2. okt. 2026 · NCT07233239RENAISSANCE 2: SPN-817 Phase 2, Double-Blind, Placebo-Controlled Study in Adults With Focal Onset Seizures
- Northeast Regional Epilepsy Group - Hackensack, Hackensack
- Hackensack Meridian Health Jersey Shore University Medical Center, Neptune City
RekruttererFase 2
Alder 18 til 70 · Alle køn · Opdateret 1. okt. 2026 · NCT06798896Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Focal Seizures FOCUS-1
- Northeast Regional Epilepsy Group, Hackensack
- Institute of Neurology and Neurosurgery at St. Barnabas, Livingston
RekruttererFase 3
Alder 18 til 75 · Alle køn · Opdateret 1. okt. 2026 · NCT07563881A Study of EPX-100 (Clemizole Hydrochloride) in Participants With Dravet Syndrome
- Neurology Center for Epilepsy and Seizures, Marlboro
RekruttererFase 3
Alder 2 og opefter · Alle køn · Opdateret 15. sep. 2026 · NCT04462770A Randomized Study of XEN1101 Versus Placebo in Focal-Onset Seizures (X-TOLE3)
- Northeast Regional Epilepsy Group, Hackensack
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 14. maj 2026 · NCT05716100Investigate Efficacy and Safety of Carisbamate as Adjunctive Treatment for Seizures Associated With LGS in Children and Adults
- Northeast Regional Epilepsy Group, Hackensack
RekruttererFase 3
Alder 4 til 55 · Alle køn · Opdateret 24. jul. 2025 · NCT05219617An Open Label Trial to Evaluate the Efficacy and Safety of PRAX-628 in Adults With Focal Onset or Tonic-Clonic Seizures
- Praxis Research Site, Hackensack
RekruttererFase 2
Alder 18 til 75 · Alle køn · Opdateret 3. apr. 2025 · NCT06908356Fra ClinicalTrials.gov, data hentet 4. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.